Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 7 (2010), Issue 11 (November)

1. Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: a report from the children's oncology group.
   J Pediatr Surg, 45(11): 2160-8. [Abstract] [Full-text]
2. Gamma Knife surgery for arteriovenous malformations in children.
   J Neurosurg Pediatr, 6(5): 426-34. [Abstract] [Full-text]
3. Stereotactic radiosurgery for pediatric recurrent intracranial ependymomas.
   J Neurosurg Pediatr, 6(5): 417-23. [Abstract] [Full-text]
4. The heritability of G2 chromosomal radiosensitivity and its association with cancer in Danish cancer survivors and their offspring.
   Int J Radiat Biol, 86(11): 986-95. [Abstract] [Full-text]
5. Pretargeted 177Lu radioimmunotherapy of carcinoembryonic antigen-expressing human colonic tumors in mice.
   J Nucl Med, 51(11): 1780-7. [Abstract] [Full-text]
6. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
   Lancet Oncol, 11(11): 1036-47. [Abstract] [Full-text]
7. Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies.
   J Nucl Med, 51(11): 1748-55. [Abstract] [Full-text]
8. No long-term effects of hormonal therapy preceding brachytherapy on urinary function and health-related quality of life among prostate cancer patients.
   Urology, 76(5): 1150-6. [Abstract] [Full-text]
9. Acute lower urinary tract symptoms after prostate brachytherapy with cesium-131.
   Urology, 76(5): 1143-7. [Abstract] [Full-text]
10. Real-time intraoperative computed tomography assessment of quality of permanent interstitial seed implantation for prostate cancer.
    Urology, 76(5): 1138-42. [Abstract] [Full-text]
11. Five year biochemical recurrence free survival for intermediate risk prostate cancer after radical prostatectomy, external beam radiation therapy or permanent seed implantation.
    Urology, 76(5): 1251-7. [Abstract] [Full-text]
12. Early complications of cystectomy after high dose pelvic radiation.
    J Urol, 184(6): 2264-9. [Abstract] [Full-text]
13. Early complications of cystectomy after high dose pelvic radiation.
    J Urol, 184(6): 2264-9. [Abstract] [Full-text]
14. The role of radiotherapy in the management of thymic tumors.
    Thorac Surg Clin, 21(1): 99-105, vii. [Abstract] [Full-text]
15. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
    Cancer Treat Rev, 36(8): 606-14. [Abstract] [Full-text]
16. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
    Cancer Treat Rev, 36(8): 606-14. [Abstract] [Full-text]
17. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
    Cancer Treat Rev, 36(8): 606-14. [Abstract] [Full-text]
18. Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.
    Blood, 116(20): 4231-9. [Abstract] [Full-text]
19. Predicting hematologic toxicity in patients undergoing radioimmunotherapy with 90Y-ibritumomab tiuxetan or 131I-tositumomab.
    J Nucl Med, 51(12): 1878-84. [Abstract] [Full-text]
20. Impact of prolonged fraction delivery times simulating IMRT on cultured nasopharyngeal carcinoma cell killing.
    Int J Radiat Oncol Biol Phys, 78(5): 1541-7. [Abstract] [Full-text]
21. 90Y Bremsstrahlung imaging for absorbed-dose assessment in high-dose radioimmunotherapy.
    J Nucl Med, 51(12): 1974-8. [Abstract] [Full-text]
22. Combining carbon ion radiotherapy and local injection of α-galactosylceramide-pulsed dendritic cells inhibits lung metastases in an in vivo murine model.
    Int J Radiat Oncol Biol Phys, 78(5): 1524-31. [Abstract] [Full-text]
23. Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer.
    Int J Radiat Oncol Biol Phys, 78(5): 1594-603. [Abstract] [Full-text]
24. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
    Int J Radiat Oncol Biol Phys, 78(5): 1356-65. [Abstract] [Full-text]
25. Quality assessment of frameless fractionated stereotactic radiotherapy using cone beam computed tomography.
    Int J Radiat Oncol Biol Phys, 78(5): 1586-93. [Abstract] [Full-text]
26. Dosimetric impact of online correction via cone-beam CT-based image guidance for stereotactic lung radiotherapy.
    Int J Radiat Oncol Biol Phys, 78(5): 1571-8. [Abstract] [Full-text]
27. The use of categorized time-trend reporting of radiation oncology incidents: a proactive analytical approach to improving quality and safety over time.
    Int J Radiat Oncol Biol Phys, 78(5): 1548-54. [Abstract] [Full-text]
28. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion.
    Int J Radiat Oncol Biol Phys, 78(5): 1579-85. [Abstract] [Full-text]
29. A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer.
    Int J Radiat Oncol Biol Phys, 78(5): 1420-6. [Abstract] [Full-text]
30. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation.
    Int J Radiat Oncol Biol Phys, 78(5): 1387-93. [Abstract] [Full-text]
31. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys, 78(5): 1373-80. [Abstract] [Full-text]
32. Measuring interfractional and intrafractional motion with cone beam computed tomography and an optical localization system for lower extremity soft tissue sarcoma patients treated with preoperative intensity-modulated radiation therapy.
    Int J Radiat Oncol Biol Phys, 78(5): 1437-44. [Abstract] [Full-text]
33. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma.
    Int J Radiat Oncol Biol Phys, 78(5): 1445-50. [Abstract] [Full-text]
34. Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis.
    Int J Radiat Oncol Biol Phys, 78(5): 1413-9. [Abstract] [Full-text]
35. Initial experience with volumetric IMRT (RapidArc) for intracranial stereotactic radiosurgery.
    Int J Radiat Oncol Biol Phys, 78(5): 1457-66. [Abstract] [Full-text]
36. Predicting hematologic toxicity in patients undergoing radioimmunotherapy with 90Y-ibritumomab tiuxetan or 131I-tositumomab.
    J Nucl Med, 51(12): 1878-84. [Abstract] [Full-text]
37. Impact of prolonged fraction delivery times simulating IMRT on cultured nasopharyngeal carcinoma cell killing.
    Int J Radiat Oncol Biol Phys, 78(5): 1541-7. [Abstract] [Full-text]
38. 90Y Bremsstrahlung imaging for absorbed-dose assessment in high-dose radioimmunotherapy.
    J Nucl Med, 51(12): 1974-8. [Abstract] [Full-text]
39. Combining carbon ion radiotherapy and local injection of α-galactosylceramide-pulsed dendritic cells inhibits lung metastases in an in vivo murine model.
    Int J Radiat Oncol Biol Phys, 78(5): 1524-31. [Abstract] [Full-text]
40. Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer.
    Int J Radiat Oncol Biol Phys, 78(5): 1594-603. [Abstract] [Full-text]
41. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
    Int J Radiat Oncol Biol Phys, 78(5): 1356-65. [Abstract] [Full-text]
42. Quality assessment of frameless fractionated stereotactic radiotherapy using cone beam computed tomography.
    Int J Radiat Oncol Biol Phys, 78(5): 1586-93. [Abstract] [Full-text]
43. Dosimetric impact of online correction via cone-beam CT-based image guidance for stereotactic lung radiotherapy.
    Int J Radiat Oncol Biol Phys, 78(5): 1571-8. [Abstract] [Full-text]
44. The use of categorized time-trend reporting of radiation oncology incidents: a proactive analytical approach to improving quality and safety over time.
    Int J Radiat Oncol Biol Phys, 78(5): 1548-54. [Abstract] [Full-text]
45. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion.
    Int J Radiat Oncol Biol Phys, 78(5): 1579-85. [Abstract] [Full-text]
46. A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer.
    Int J Radiat Oncol Biol Phys, 78(5): 1420-6. [Abstract] [Full-text]
47. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation.
    Int J Radiat Oncol Biol Phys, 78(5): 1387-93. [Abstract] [Full-text]
48. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys, 78(5): 1373-80. [Abstract] [Full-text]
49. Measuring interfractional and intrafractional motion with cone beam computed tomography and an optical localization system for lower extremity soft tissue sarcoma patients treated with preoperative intensity-modulated radiation therapy.
    Int J Radiat Oncol Biol Phys, 78(5): 1437-44. [Abstract] [Full-text]
50. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma.
    Int J Radiat Oncol Biol Phys, 78(5): 1445-50. [Abstract] [Full-text]
51. Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis.
    Int J Radiat Oncol Biol Phys, 78(5): 1413-9. [Abstract] [Full-text]
52. Initial experience with volumetric IMRT (RapidArc) for intracranial stereotactic radiosurgery.
    Int J Radiat Oncol Biol Phys, 78(5): 1457-66. [Abstract] [Full-text]
53. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).
    Ann Surg, 252(6): 998-1004. [Abstract] [Full-text]
54. A radiotherapy planning study of RapidArc, intensity modulated radiotherapy, three-dimensional conformal radiotherapy, and parallel opposed beams in the treatment of pediatric retroperitoneal tumors.
    Pediatr Blood Cancer, 56(1): 16-23. [Abstract] [Full-text]
55. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).
    Ann Surg, 252(6): 998-1004. [Abstract] [Full-text]
56. A radiotherapy planning study of RapidArc, intensity modulated radiotherapy, three-dimensional conformal radiotherapy, and parallel opposed beams in the treatment of pediatric retroperitoneal tumors.
    Pediatr Blood Cancer, 56(1): 16-23. [Abstract] [Full-text]
57. A radiotherapy planning study of RapidArc, intensity modulated radiotherapy, three-dimensional conformal radiotherapy, and parallel opposed beams in the treatment of pediatric retroperitoneal tumors.
    Pediatr Blood Cancer, 56(1): 16-23. [Abstract] [Full-text]
58. A radiotherapy planning study of RapidArc, intensity modulated radiotherapy, three-dimensional conformal radiotherapy, and parallel opposed beams in the treatment of pediatric retroperitoneal tumors.
    Pediatr Blood Cancer, 56(1): 16-23. [Abstract] [Full-text]
59. Swelling of the prostate gland by permanent brachytherapy may affect seed migration.
    Jpn J Clin Oncol, 40(12): 1159-65. [Abstract] [Full-text]
60. Swelling of the prostate gland by permanent brachytherapy may affect seed migration.
    Jpn J Clin Oncol, 40(12): 1159-65. [Abstract] [Full-text]
61. Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.
    J Clin Oncol, 28(34): 5061-6. [Abstract] [Full-text]

© 2004-2012 Radiotherapy Research Today. All Rights Reserved.